Guggenheim Downgrades Spruce Biosciences, Inc. (SPRB) to Neutral
Guggenheim analyst Evan Wang downgraded Spruce Biosciences, Inc. (NASDAQ: SPRB) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
